Published in Am J Cardiol on January 15, 2004
Multi-Center Human Alert Trial to Prevent DVT and PE | NCT00409136
Discharge ALERT: Quality Improvement Initiative (Discharge) | NCT00853463
Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ (2012) 1.78
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66
Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis (2010) 1.26
Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med (2007) 1.11
Practices to prevent venous thromboembolism: a brief review. BMJ Qual Saf (2013) 1.08
Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. PLoS One (2013) 1.08
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig Dis Sci (2012) 0.98
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res (2007) 0.95
Optional vena cava filters: indications, management, and results. Dtsch Arztebl Int (2009) 0.89
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes. J Am Heart Assoc (2013) 0.86
Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84
Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship? Dis Colon Rectum (2014) 0.84
Venous thromboembolism prophylaxis in the United States: still room for improvement. J Gen Intern Med (2010) 0.83
The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital. Thromb J (2014) 0.82
Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82
The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats. PLoS One (2010) 0.82
Increased risk of venous thromboembolism is associated with genetic variation in heme oxygenase-1 in Blacks. Thromb Res (2012) 0.81
Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve. Ann Thorac Med (2010) 0.80
Cancer-associated thrombosis. Open Cardiovasc Med J (2010) 0.80
Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn (2006) 0.80
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag (2009) 0.80
Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example. Med Care (2015) 0.79
Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study. BMJ Open (2014) 0.79
Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge. Thromb J (2011) 0.79
Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study. Thromb J (2014) 0.78
Impact of Introducing Anticoagulation-Related Prescribing Guidelines in a Hospital Setting using Academic Detailing. Ther Clin Risk Manag (2006) 0.78
Hospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready? Saudi Pharm J (2012) 0.77
Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina. Thromb J (2011) 0.77
Prevention and treatment of venous thromboembolism in the elderly patient. Clin Interv Aging (2007) 0.77
Prevention of venous thromboembolism in medically ill patients: a clinical update. Postgrad Med J (2006) 0.77
The role of thrombophilia in pregnancy. Thrombosis (2013) 0.77
Antithrombotic prophylaxis in the middle East. Mediterr J Hematol Infect Dis (2011) 0.76
Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009). Thromb Res (2015) 0.75
Epidemiological African day for evaluation of patients at risk of venous thrombosis in acute hospital care settings. Cardiovasc J Afr (2014) 0.75
Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients. Thrombosis (2015) 0.75
Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus (2016) 0.75
Knowledge of thromboprophylaxis guidelines pre- and post-didactic lectures during a venous thromboembolism awareness day at a tertiary-care hospital. Ann Thorac Med (2013) 0.75
Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther (2016) 0.75
Adherence to Venous Thromboprophylaxis Guidelines for Medical and Surgical Inpatients of Teaching Hospitals, Shiraz-Iran. Tanaffos (2015) 0.75
Association between hypertension and deep vein thrombosis after orthopedic surgery: a meta-analysis. Eur J Med Res (2016) 0.75
Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers. J Am Med Inform Assoc (2014) 0.75
The Prediction of the Risk Level of Pulmonary Embolism and Deep Vein Thrombosis through Artificial Neural Network. Acta Inform Med (2016) 0.75
Pregnancy-associated pulmonary embolism during the peripartum period: An 8-year experience at a single center. Obstet Gynecol Sci (2014) 0.75
Deep venous thrombosis among diabetic patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia. Electron Physician (2017) 0.75
Effectiveness of two distinct web-based education tools for bedside nurses on medication administration practice for venous thromboembolism prevention: A randomized clinical trial. PLoS One (2017) 0.75
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med (2010) 5.79
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med (2003) 3.90
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med (2008) 3.68
Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med (2007) 3.16
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol (2010) 2.55
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol (2005) 1.97
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med (2006) 1.86
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest (2003) 1.71
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A (2005) 1.67
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67
End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.63
Outcome of lung transplantation in patients with mycetomas. Chest (2002) 1.59
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension. J Cardiovasc Pharmacol (2013) 1.55
Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol (2005) 1.42
SPECT in acute pulmonary embolism. J Nucl Med (2009) 1.40
Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension. J Cardiovasc Pharmacol (2016) 1.39
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol (2003) 1.37
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med (2005) 1.35
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol (2004) 1.24
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost (2010) 1.21
Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine. Int J Cardiovasc Imaging (2011) 1.17
Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III. Int J Cardiovasc Imaging (2011) 1.11
Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. Chest (2009) 1.11
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest (2013) 1.10
Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg (2005) 1.10
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant (2011) 1.09
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost (2005) 1.04
Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med (2002) 1.03
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg (2010) 1.02
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med (2008) 1.00
American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology (2012) 0.99
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol. J Rheumatol (2009) 0.97
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis (2011) 0.97
An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med (2011) 0.97
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther (2013) 0.94
Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest (2002) 0.94
Severe erythroderma as a complication of continuous epoprostenol therapy. Chest (2002) 0.93
Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension. Semin Respir Crit Care Med (2005) 0.92
D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism. AJR Am J Roentgenol (2009) 0.89
Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy. J Am Acad Dermatol (2004) 0.88
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med (2010) 0.87
Gender differences in the administration of prophylaxis to prevent deep venous thrombosis. Thromb Haemost (2005) 0.86
Diagnosis of pulmonary embolism in the coronary care unit. Am J Cardiol (2009) 0.85
High utilization rate of vena cava filters in deep vein thrombosis. Thromb Haemost (2005) 0.85
Chronic thromboembolic pulmonary hypertension. Semin Thromb Hemost (2006) 0.85
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. J Heart Lung Transplant (2007) 0.84
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J (2009) 0.83
One-year experience with intravenous treprostinil for pulmonary arterial hypertension. J Heart Lung Transplant (2013) 0.83
Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82
Lung transplantation and atrial septostomy in pulmonary arterial hypertension. Clin Chest Med (2013) 0.81
Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost (2010) 0.81
Venous thromboembolism in intensive care patients. Clin Chest Med (2003) 0.80
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis (2006) 0.80
Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. Am J Med (2012) 0.79
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study. Stroke (2012) 0.78
Diagnosing and managing acute pulmonary embolism: role of cardiac troponins. Am Heart J (2003) 0.76
The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. Am Heart J (2005) 0.76
Road ahead to respiratory health: experts chart future research directions. Respirology (2009) 0.76
Clinical probability and D-dimer testing: how should we use them in clinical practice? Semin Respir Crit Care Med (2008) 0.75
Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel. J Vasc Interv Radiol (2005) 0.75
Right ventricular responses to massive and submassive pulmonary embolism. Cardiol Clin (2012) 0.75
Thrombolytic therapy for venous thromboembolism: current clinical practice. J Hosp Med (2009) 0.75
Few predictors of massive deep vein thrombosis. Thromb Haemost (2005) 0.75
Protect your health in the air. Most people with chronic health conditions can travel by air safely--if they take a few precautions. Health News (2002) 0.75
[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]. Presse Med (2011) 0.75
The diagnosis of acute venous thromboembolism. Dis Mon (2005) 0.75
Commentary: Persistent gaps in VTE prophylaxis in orthopedic surgery: will new educational strategies help? Am J Med Qual (2011) 0.75
[Treatment goals of pulmonary hypertension]. Turk Kardiyol Dern Ars (2014) 0.75
Prophylaxis for venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis (2011) 0.75
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial. Thromb Haemost (2013) 0.75
Managing pulmonary arterial hypertension and optimizing treatment options. Introduction. Am J Cardiol (2013) 0.75